Articles

Innovative Packaging And Materials - Why It Matters | Newsletter | Issue 02 | 2020

Innovative Packaging And Materials - Why It Matters | Newsletter | Issue 02 | 2020

Very often, companies still view product packaging as an afterthought. So much time, money, and care go into the creation and perfection of their products, but if it’s not packaged properly, all those efforts might go to waste.  Learn now MediZap's unique packaging offers can help your compounding pharmacy or outsourcing facility build awareness and trust with your customers.  Why Is Packaging Important? In today’s design-focused environment, customers place equal importance on the quality of your packaging design and the functionality of your product. The most important aspect of your marketing is arguably your product packaging.  Packaging is no longer...

Read more →


Clinical Utility of Treating Individuals with Compounded “Bioidentical Hormone Replacement Therapy” | Newsletter | Issue 01 | 2020

Clinical Utility of Treating Individuals with Compounded “Bioidentical Hormone Replacement Therapy” | Newsletter | Issue 01 | 2020

What are the benefits of treating people with compounded “Bioidentical Hormone Replacement Therapy (BHRT)”? A diverse committee from the National Academies of Sciences, Engineering and Medicine, in partnership with the FDA, will carry out a report to measure the clinical power of treating individuals with compounded "bioidentical hormone replacement therapy (BHRT)” medications. The committee will: Review the existing patient history of compounded BHRT medications, and other compounded products, and to document the care of patients, including the conditions compounded medications have showcased in their history. Describe the physical and chemical substance characteristics of compounded BHRT medications (example: active components, inactive...

Read more →


Changes In the New USP 797 Regulations | Newsletter | Issue 01 | 2020

Changes In the New USP 797 Regulations | Newsletter | Issue 01 | 2020

  In 2019, revisions were published to the USP General Chapter 797 Pharmaceutical Compounding – Sterile Preparations, by the Compounding Expert Committee of the US Pharmacopeia Convention, on compounding nonsterile and sterile preparations, along with advanced standards for compounding radiopharmaceutical drugs. This is one of the first changes to the original regulation set of sterile compounding practice standards given by the United States Pharmacopeia (USP). The updates advocate for change in both structure and content, forcing processes to broaden and to increasingly become more effective. Below outlines the significant details that will most influence sterilization and depyrogenation. Compounded Sterile Preparation...

Read more →


Time Sensitive Cold Chain Solutions | Newsletter | Issue 01 | 2020

Time Sensitive Cold Chain Solutions | Newsletter | Issue 01 | 2020

Cold chain solutions have become increasingly used in global healthcare economies. Billions of dollars are being invested in temperature-controlled transportation methods in the medical industry, most focused on pharmaceuticals. This system has progressively developed into the favored shipping choice when it comes to logistics because temperature-controlled pharmaceuticals allow for extended beyond use dates saving practitioners and hospitals millions of dollars. Cold chains are a temperature-controlled supply chain that requires consistent refrigeration or frozen temperatures from the moment the pharmaceutical is being manufactured through shipping, sterilization, all the way to delivery. Mandates require this technology to preserve and maintain the integrity...

Read more →